338 related articles for article (PubMed ID: 25282326)
1. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
[TBL] [Abstract][Full Text] [Related]
2. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France.
Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Pornet C; Sarlin N; Lunaud P; Desmidt P; Quantin C; Chauvin F; Dancourt V; Arveux P
Prev Med; 2014 Jun; 63():103-8. PubMed ID: 24345603
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.
Duport N
Rev Epidemiol Sante Publique; 2012 Dec; 60(6):421-30. PubMed ID: 23146369
[TBL] [Abstract][Full Text] [Related]
4. [Breast cancer screening in thirteen French departments].
Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Dialla PO; Pornet C; Poillot ML; Soler-Michel P; Sarlin N; Lunaud P; Desmidt P; Paré E; Mathis C; Rymzhanova R; Kuntz-Huon J; Exbrayat C; Bataillard A; Régnier V; Kalecinski J; Quantin C; Dumas A; Gentil J; Amiel P; Chauvin F; Dancourt V; Arveux P
Bull Cancer; 2015 Feb; 102(2):126-38. PubMed ID: 25636359
[TBL] [Abstract][Full Text] [Related]
5. Understanding barriers to organized breast cancer screening in France: women's perceptions, attitudes, and knowledge.
Ferrat E; Le Breton J; Djassibel M; Veerabudun K; Brixi Z; Attali C; Renard V
Fam Pract; 2013 Aug; 30(4):445-51. PubMed ID: 23478254
[TBL] [Abstract][Full Text] [Related]
6. Proportion of women with self-reported opportunistic mammography before organized screening.
Heikkinen S; Miettinen J; Koskenvuo M; Huovinen R; Pitkäniemi J; Sarkeala T; Malila N
Acta Oncol; 2016 Jul; 55(7):865-9. PubMed ID: 27144814
[TBL] [Abstract][Full Text] [Related]
7. Study of socio-economic characteristics, diagnosis and outcome of women participating or not participating in mammogram screening.
Padoan M; Ferrante D; Pretti G; Magnani C
Ann Ig; 2014; 26(6):518-26. PubMed ID: 25524076
[TBL] [Abstract][Full Text] [Related]
8. Overuse of mammography during the first round of an organized breast cancer screening programme.
Chamot E; Charvet A; Perneger TV
J Eval Clin Pract; 2009 Aug; 15(4):620-5. PubMed ID: 19522725
[TBL] [Abstract][Full Text] [Related]
9. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
Nash D; Chan C; Horowitz D; Vlahov D
J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
[TBL] [Abstract][Full Text] [Related]
10. Participation of the Women Covered by Family Physicians in Breast Cancer Screening Program in Kerman, Iran.
Jafari M; Nakhaee N; Goudarzi R; Zehtab N; Barouni M
Asian Pac J Cancer Prev; 2015; 16(11):4555-61. PubMed ID: 26107203
[TBL] [Abstract][Full Text] [Related]
11. [Organized or individual breast cancer screening: what motivates women?].
Kalecinski J; Régnier-Denois V; Ouédraogo S; Dabakuyo-Yonli TS; Dumas A; Arveux P; Chauvin F
Sante Publique; 2015; 27(2):213-20. PubMed ID: 26414035
[TBL] [Abstract][Full Text] [Related]
12. The effect of organized breast cancer screening on mammography use: Evidence from France.
Buchmueller TC; Goldzahl L
Health Econ; 2018 Dec; 27(12):1963-1980. PubMed ID: 30084221
[TBL] [Abstract][Full Text] [Related]
13. "I come because I am called": recruitment and participation in mammography screening in Uppsala, Sweden.
Willis K
Health Care Women Int; 2008 Feb; 29(2):135-50. PubMed ID: 18350420
[TBL] [Abstract][Full Text] [Related]
14. Mammographic screening programmes in Europe: organization, coverage and participation.
Giordano L; von Karsa L; Tomatis M; Majek O; de Wolf C; Lancucki L; Hofvind S; Nyström L; Segnan N; Ponti A; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J J; Lancucki L; Ducarroz S; Suonio E
J Med Screen; 2012; 19 Suppl 1():72-82. PubMed ID: 22972813
[TBL] [Abstract][Full Text] [Related]
15. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
Constantinou P; Dray-Spira R; Menvielle G
BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
[TBL] [Abstract][Full Text] [Related]
16. [Attendance in the Norwegian Breast Cancer Screening Programme].
Sebuødegård S; Sagstad S; Hofvind S
Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204
[TBL] [Abstract][Full Text] [Related]
17. [Mammography and cervical cancer screening--a systematic review about women's knowledge, attitudes and participation in Germany].
Dreier M; Borutta B; Töppich J; Bitzer EM; Walter U
Gesundheitswesen; 2012 Nov; 74(11):722-35. PubMed ID: 22012563
[TBL] [Abstract][Full Text] [Related]
18. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of breast cancer screening in Côte d'Or (France): clinical implications and factors affecting screening round adequacy.
Ouedraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
Eur J Cancer Prev; 2011 Nov; 20(6):462-74. PubMed ID: 22025137
[TBL] [Abstract][Full Text] [Related]
20. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
